Skip main navigation

Noncontrast Magnetic Resonance Angiography for the Diagnosis of Peripheral Vascular Disease

Originally publishedhttps://doi.org/10.1161/CIRCIMAGING.118.008844Circulation: Cardiovascular Imaging. 2019;12:e008844

    Abstract

    Contrast-enhanced magnetic resonance angiography (MRA) provides excellent assessment of the peripheral arterial vasculature and is considered an important adjunctive diagnostic modality for the assessment of peripheral arterial disease. However, given the high prevalence of chronic kidney disease in patients with peripheral arterial disease, the association of gadolinium contrast media with nephrogenic systemic fibrosis, and recent concern with consequences of long-term deposition of gadolinium in the brain, there has been a renewed interest in noncontrast MRA approaches. Recent improvements in pulse sequences combined with instrumentation have facilitated the development of newer noncontrast MRA sequences that provide high spatial resolution, allowing the evaluation of distal (infrageniculate and pedal) vessels of importance in patients with critical limb ischemia. Further, many of these sequences are time efficient and versatile, allowing rapid evaluation of the entire lower extremity vasculature. In this comprehensive review, we outline historic techniques and compare these with newer approaches such as quiescent interval slice-selective MRA, 3-dimensional fast spin echo , and velocity-sensitive MRA that are emerging as an alternative to computed tomographic angiography or digital subtraction angiography for the evaluation of lower limb arteries in patients with peripheral arterial disease. Technical details and applications in clinical practice will be discussed.

    The assessment of the peripheral vascular system using magnetic resonance imaging has had extensive clinical validation in patients with lower extremity arterial disease.1,2 Recent advances in magnetic resonance (MR) hardware (eg, high-performance gradients and multichannel receive coil arrays), pulse sequences (eg, rapid gradient-echo-based sequences), and image reconstruction algorithms (eg, parallel imaging) have facilitated rapid imaging with high spatial resolution and signal to noise ratio (SNR), particularly to image distal vessels. Contrast-enhanced MR angiography (CE-MRA) performed with gadolinium-based contrast is a worthy alternative to computed tomography angiography (CTA) and avoids exposing patients to iodinated contrast material and ionizing radiation. However, given the high prevalence of chronic kidney disease in patients with peripheral vascular disease3 and the association of gadolinium-based contrast media and nephrogenic systemic fibrosis in patients with severe chronic kidney disease,4 contrast-free alternatives to CE-MRA are appealing. Moreover, the recent concerns with long-term deposition of gadolinium in the brain and bones have further strengthened interest in noncontrast MRA (NC-MRA) approaches.5–8

    In the past several years, review articles summarizing NC-MRA techniques used for diagnosis of disease in various vascular districts have been written.9,10 The purpose of our review is to summarize technological advances and the most appropriate techniques for the study of lower limb arteries in patients with peripheral arterial disease (PAD). Both established and emerging NC-MRA techniques for evaluating the lower extremities are contrasted, and a clinical perspective on the utility of these techniques and their advantages has been provided.

    Inflow-Based Techniques

    Time of Flight

    Time of flight (TOF) is the oldest NC-MRA technique, with contrast in the technique based on the differences in magnetization (manifested as magnetic resonance imaging signal intensity) between the flowing blood and stationary tissue. Flow-related signal enhancement is created when the inflowing unsaturated blood enters the imaging slice, so it can be subject to an radiofrequency (RF) excitation pulses and can be replenished by free unsaturated blood before the next RF pulse, while the stationary tissue in the imaging slice experiences repeated RF pulses, suppressing longitudinal magnetization and therefore signal. Gradient-echo imaging readouts are used for TOF imaging, with the slice oriented in an axial plane approximately perpendicular to the primary direction of vascular flow. As needed, venous or arterial blood suppression is achieved by using selective saturation pulses that are applied parallel and adjacent to the imaging slices (either below or above) to create either arteriograms or venograms, respectively. Two-dimensional TOF of the lower extremities requires the use of cardiac gating to avoid ghost artifacts related to multiphasic flow in healthy lower extremity arteries. In TOF imaging, vascular signal intensity depends on the amount of unsaturated blood in the slice at the time of sampling, which in turn depends on blood velocity, repetition time (TR) between applied RF pulses, and thickness of the imaging slice (Figure I in the Data Supplement). In general, thinner slices, faster-flowing blood, vessels oriented perpendicular to the slice, and a longer TR increase vascular signal. The use of a long TR, however, increases signal from stationary tissue and lengthens the acquisition time, so an intermediate to short TR is often selected. Short echo time values (<7 ms) are used to minimize phase dispersion–related signal loss from accelerating or turbulent blood flow near stenosis. In addition, larger flip angle leads to reduced signal from stationary tissue, but it can also result in increased saturation of blood experiencing multiple excitation pulses. Thus, a flip angle that balances these 2 competing priorities is typically chosen (usually 30°−60° are used). If the distance traveled by blood in each TR is greater or equal to the slice thickness, the entire volume of blood within the slice is replaced by new fresh blood, allowing generation of high vascular signal. If a portion of the unsaturated blood volume is replaced by saturated blood, because of repeated RF pulses, this may result in lower vascular signal. Additional loss of signal may occur due to flow-induced spin dephasing caused by the magnetic field gradients used for imaging and may be reduced by the use of flow-compensated imaging gradients.11

    Clinical Utility and Preferred Vascular Application(s)

    TOF imaging is sparingly used for NC-MRA of lower extremity peripheral vascular disease because of the existence of newer protocols that provide improved image quality and shorter scan times and its susceptibility to artifacts (partial saturation effects related to in-plane flow and flow-related turbulence) that may mimic or exaggerate a stenosis.12,13 The application of parallel imaging approaches such as compressed sensing may reduce scan times and improve image quality of TOF-based protocols, although the clinical utility of such approaches remains to be determined.14 TOF, however, remains a popular technique for the evaluation of the extracranial and intracranial arteries.13

    Quiescent Interval Slice-Selective MRA

    Quiescent interval slice-selective (QISS) MRA is a cardiac (ie, electrocardiogram [EKG])-gated technique initially described by Edelman et al15 for the evaluation of the lower extremities. A recent review article by Edelman et al10 focuses on new developments and implementations of this technique. Our purpose is to describe the basics principles and the evidence about the application in clinical practice for the evaluation of PAD of this approach.

    This technique uses a single-shot 2D balanced steady-state free precession (bSSFP) readout, which addresses many of the limitations of TOF imaging by reducing scan times and arterial saturation effects and leveraging the pulsatile nature of blood flow to better visualize lower extremity arteries. After detection of the EKG R-wave, a slice-selective saturation RF pulse is applied to the imaging plane, and a tracking venous saturation RF pulse is applied below the imaging slice. The 2 saturation pulses are followed by a quiescent interval phase (≈280 ms) that overlaps systole during which fully magnetized arterial blood (not affected by the in-plane saturation pulse) flows into the imaging slice. Alignment of the quiescent interval with the systolic phase of rapid blood flow ensures adequate inflow into the imaging slice; the quiescent interval is also short enough to maintain good suppression of stationary background tissue (Figure II in the Data Supplement). Following the quiescent interval, a frequency-selective fat saturation RF pulse is applied immediately before data acquisition to suppress the appearance of fat signal, which would otherwise appear bright. A single-shot bSSFP image acquisition is thereafter applied because it provides high signal from blood, allowing for time-efficient imaging of a single slice in each heartbeat (Figure 1). The sequence of saturation pulses, quiescent interval, and single-shot acquisition is repeated over many sequentially acquired contiguous or overlapping slices to cover the anatomy of interest.

    Figure 1.

    Figure 1. Quiescent interval slice-selective (QISS) noncontrast magnetic resonance angiography. Examples of arteriogram (A) and venogram (B).

    Due to the use of a quiescent interval that overlaps, systole QISS MRA is effective in low-flow situations and is, therefore, particularly suited for angiographic evaluation of the lower extremities. It is also robust against motion and cardiac arrhythmias due to the use of single-shot acquisition. Other advantages include ease of use, as no protocol tailoring is necessary, and the relatively quick scan time that allows full coverage of the entire peripheral arteries (from pelvis to ankles) in ≈7 minutes (excluding the time for shimming). Venography is possible with QISS MRA by flipping the location of the tracking saturation pulse (to suppress arteries instead of veins) and lengthening the quiescent interval to accommodate the inflow of slower venous blood into the imaging slice (Figure 1). Example of QISS in patients with PAD is depicted in Figure 2. Potential limitations include suppression of in-plane-oriented vessel segments that reside within the saturation region and limited superior-inferior resolution due to limited minimal slice thickness. The use of a bSSFP readout renders QISS sensitive to potential off-resonance artifacts from metallic implants (eg, prostheses and stents) and air-filled bowel loops in the pelvis located near the arteries.

    Figure 2.

    Figure 2. Comparison of different angiography techniques. Patient with bilateral superficial femoral artery occlusions and substantial aorto-iliac calcification imaged with quiescent interval slice-selective noncontrast magnetic resonance angiography (QISS NC-MRA; A), contrast-enhanced MR angiography (CE-MRA; B), and computed tomography angiography (CTA; C). QISS NC-MRA demonstrates the femoral artery occlusions (arrows) and shows excellent correlation with CTA and CE-MRA.

    Clinical Utility and Preferred Vascular Application(s)

    When compared with either digital subtraction angiography (DSA) or CE-MRA as the reference standard examination, QISS MRA demonstrates high sensitivity and specificity for the detection of ≥50% stenosis of the lower extremities. Across 8 studies16–22 using DSA as the reference standard exam (153 total patients), median values for the sensitivity and specificity of QISS NC-MRA were 91.4% and 96.4%, respectively. In 9 studies16–19,23–27 using CE-MRA as the reference standard examination (254 total patients), median values for the sensitivity and specificity of QISS were 89.2% and 96.0%, respectively (Table 1).

    At 3 Tesla, the performance of QISS appears to be slightly better with 92.7% sensitivity and 95.6% specificity with respect to DSA (81 total patients) and 89.2% sensitivity and 96.1% specificity with respect to CE-MRA (129 total patients). QISS has also shown good accuracy in patients with glomerular filtration rates ≤60 mL/min per 1.73 m2 and diabetes mellitus.16,17 In comparison with CTA, QISS demonstrates better sensitivity and specificity for >50% stenosis (Table 1), with high inter-observer agreement. Moreover, QISS is reportedly less prone to artifacts than CTA and better portrays heavily calcified vessels.21,29 Other more recent applications of QISS include the evaluation of the coronary, pulmonary, extracranial carotid, and intracranial arteries,42–45 with some protocols leveraging radial k-space sampling and spoiled gradient-echo readouts to improve image quality and combat local magnetic field inhomogeneity.

    The original implementations of QISS have been shown to be reliable for the evaluation of PAD although with some limitations related to suppression of in-plane-oriented vessel segments residing within the saturation region and the sensitivity to off-resonance artifacts (Table 2). These features render QISS suitable for lower limb arteries evaluation in patients with known or suspected PAD to assess the degree of stenosis. However, arterial districts where susceptibility artifacts are less likely to occur and especially in long vertical segments (eg, with no metallic elements or air), such as femoral or calf vessels, are ideal for this technique (Table 3). QISS is also the NC-MRA technique that is used increasingly for rapid imaging of the renal and pulmonary arteries.10

    Cardiac Phase and Flow Dependent Techniques

    Three-Dimensional Fast (Turbo) Spin Echo Techniques

    Three-dimensional (3D) fast spin echo (FSE) techniques are versatile techniques that can be used to image the lower extremity circulation. While the precise implementation may vary across the manufacturer, they usually incorporate the following features: (1) 3D-fast (turbo) spin echo acquisition, (2) long echo train lengths, (3) ultrashort echo spacing, typically 3 to 4 msec, (4) nonselective refocusing pulses, (5) reduced flip angles (may be constant but usually variable, typically 30°–120°), (6) partial Fourier imaging schemes and parallel imaging approaches to reduce imaging time, (7) optimized/efficient k-space trajectories with sampling in both in-plane and through-slab phase-encode directions during signal evolution, and (8) reasonable imaging times (5–10 minutes).

    Reduced flip angle refocusing approaches result in a complex combination of spin and stimulated echoes that produce a signal that persists and depends on both T1 and T2. The use of variable (low flip angle) spatially nonselective radiofrequency refocusing pulses help suppress blurring, lengthen the useable duration of the spin-echo train, and reduce RF energy deposition and specific absorption rate.46,47 The variable flip angle pulse train typically starts with higher amplitude pulses and slowly decreases to approach a constant (asymptotic) value of longitudinal magnetization. The results are scans that are faster, with lower specific absorption rate, where the SNR (despite using lower flip angles) is close to those acquired with 180° refocusing pulses. The additional use of parallel imaging techniques and navigator gating may enable the acquisition of high-resolution 3D turbo spin echo data (isotropic <1 mm spatial resolution at 3T) that has been quite useful for the imaging of lower extremity arterial circulation.

    EKG-Gated Techniques

    The idea of using the insensitivity of spin-echo signal to flowing spins was first introduced 3 decades ago by Meuli et al48 and advanced by Miyazaki et al.49 Several identical approaches are available: NATIVE SPACE (NATIVE, noncontrast angiography of the arteries and veins; SPACE, sampling perfection with application-optimized contrast by using different flip angle

    evolution) and TRANCE (triggered angiography noncontrast enhanced).50 This technique uses EKG-gated 3D segmented FSE readouts, consisting of a 90° RF pulse followed by multiple repetitive 180° pulses (echo train). By adjusting the cardiac trigger delay time to take advantage of the differential arterial flow velocities in systolic and diastolic phases of the cardiac cycle or R-R interval, images with either bright or black arterial signal are acquired. During the systolic phase, the arterial blood is fast and yields no signal as the blood flows out of the imaged volume before experiencing the 180° RF refocusing pulses (Figure III in the Data Supplement). The slow venous blood and the stationary tissue contribute significant signal as their transverse magnetization is fully refocused through the train of 180° RF pulses. In contrast, during diastole, when arterial flow is low, all spins in the imaging volume are experiencing the refocusing RF echo train and contribute signal to the image (Figure III in the Data Supplement). When the systolic acquired image is subtracted from the diastolic image, the resultant image will depict only signal in the arterial compartment (Figure 3). Theoretically, fat signal should be zero after subtraction, but additional prepulse such as short tau inversion recovery or spectral attenuated inversion recovery is often used for more robust fat suppression.49 The flow suppression effect is generally the largest in the frequency encode direction because of the large bipolar gradient for frequency encoding. Hence, the frequency-encoded direction is typically prescribed parallel to the primary direction of arterial flow.33 The flip angle of the refocusing pulse is meant to control the degree of flow sensitivity and should be carefully adjusted. A general trade-off is that large refocusing flip angle (>160°) tends to yield more intense signal in large vessels but tends to fail to delineate small branch vessels.51 The 3D-FSE technique and its variants are relatively insensitive to B0 field variation, allowing their use with large field of view and high field strength. The limitations arise from the need for 2 separate acquisitions and properly timing the systolic and diastolic acquisitions. Moreover the degree of flow spoiling, and subtraction artifact from motion can be quite problematic in the pelvis (Table 2).

    Figure 3.

    Figure 3. Representative T2 3D SPACE syngo noncontrast angiography of the arteries and veins, maximum intensity projection, 5 steps composed. SPACE indicates sampling perfection with application-optimized contrast by using different slip angle evolution.

    Clinical Utility and Preferred Vascular Application(s)

    The relatively low sensitivity to B0 inhomogeneity allows the use of these techniques for studies of vascular districts contiguous with high susceptibility zones (eg, lungs, metallic prosthesis, and valves) or large field of view. The technique can, therefore, be used for pulmonary angiography and thoracic and abdominal aortic angiography,9 and it has demonstrated value in peripheral arterial imaging as well as whole body MRA.52 Comparison with CTA33 and CE-MRA30,32 in peripheral run-off studies has demonstrated high sensitivity and negative predictive value (Table 1). Limitations include visualization of small-caliber arteries, particularly of calf and foot district.

    Gutzeit et al31 studied cardiac gated 3D FSE in the lower limb arteries using DSA as reference standard. The study demonstrated a very high negative predictive value (>95%) and high diagnostic accuracy (>90%) for both thigh and calf segments. Schubert et al34 used the cardiac gated 3D FSE and CE-MRA for the evaluation of pedal vasculature in 20 PAD patients, with DSA as standard reference. The rate of nondiagnostic vessel segments was considerably higher for the NC-MRA technique. Sensitivity and negative predictive value for the NC-MRA were 96% and 97%, respectively, while specificity and positive predictive value were 80% and 69% for >50% stenosis, respectively. The performance of this technique in patients with severe PAD such as critical limb ischemia appears to be sub-optimal. Altaha et al22 compared cardiac gated 3D FSE with QISS in the evaluation of lower limb arteries in 19 patients with critical limb ischemia. Although QISS provided good to excellent image quality in 80% to 96% of arterial segments without any nondiagnostic arterial segments, 90% to 96% of segments obtained with 3D-FSE MRA were rated as nondiagnostic or poor, precluding the calculation of diagnostic performance measures for 3D-FSE MRA. Similarly, Ward et al24 reported inferior image quality and specificity of cardiac gated 3D-FSE (NATIVE SPACE) as compared with QISS in a cohort of patients with chronic lower limb ischemia (Table 1). These findings might be related to the low-flow velocity in systole compared with diastole in the stenotic arterial segments that can determine the suppression of the signal in the final subtracted image (Figure 4). The TRANCE technique has also been recently implemented for the lower limb arteries imaging on open, low-field MR systems showing good image quality but underestimation of larger vessels and overestimation of smaller caliber vessels compared with DSA.53

    Figure 4.

    Figure 4. Sixty-six-year-old male smoker with right-sided claudication with a stent in the distal right superficial femoral artery. Comparison between contrast-enhanced magnetic resonance angiography (MRA; A) and subtractive fast spin echo-MRA(FSE-MRA; B). Lack of arterial visualization in the right calf is evident in the subtractive FSE-MRA images. Artifact mimicking occlusion of the proximal left anterior tibial artery (arrow) is also evident. In the diagram flow variations in stenotic (yellow line) and normal (red line) arterial segments are shown. Note as the difference in flow velocity between systole and diastole is very low in the stenotic arterial segments, and this may affect the final subtracted image. Reprinted from Ward et al24 with permission. Copyright ©2013, Journal of Magnetic Resonance Imaging.

    3D-FSE sequences such as SPACE or VISTA (volume isotropic turbo spin echo acquisition) can also be used without subtraction and cardiac gating, but with additional use of a double inversion pulse, allowing for isotropic 3D of the lower extremity circulation. The sequence is useful in providing dark blood images that allow visualization of the arterial wall (Figure 5). Mihai et al46 compared SPACE to CE-MRA for the evaluation of lower limb arteries in a small group of PAD patient, showing high correlation with no significant bias in the vessel area estimation between the 2 techniques.

    Figure 5.

    Figure 5. First sentence: Example of SPACE sequence. Noncardiac gated 3D-fast spin echo of the abdominal aorta (A) and superficial femoral artery (B) demonstrating incomplete blood suppression seen as residual intraluminal signal (white thick arrows). The 3D display helps in assessing vessel wall delineation as it can rule out any other conditions that the unsuppressed blood signal may be mistaken for. Reprinted from Mihai et al52 with permission. Copyright ©2010, Journal of Magnetic Resonance Imaging. SFA indicates Superficial Femoral Artery; and SM, Superior Mesenteric Artery.

    The relatively low sensitivity to B0 inhomogeneity and the limitations related to the low image quality in the visualization of small caliber vessels of the lower extremity make this technique useful for the evaluation of the distal abdominal aorta and iliac arteries in patients with and without metallic stent or prosthesis (Table 3).

    Flow-Sensitive Dephasing Magnetization Preparation Technique

    Another noncontrast approach to visualize peripheral vasculature is the 3D bSSFP using flow-sensitive dephasing (FSD) magnetization preparation, which provides high arterial blood SNR and blood-tissue CNR, isotropic submillimeter resolution, and different velocities and flow directions suppression using a flexible FSD module. The principle of this technique is similar to the spin-echo-based technique in that bright artery, and dark artery images are acquired separately for the same imaging volume, and image subtraction is used to yield artery-only images. While the sensitivity of spin-echo readout to flow is used in the former approach to suppress the appearance of arteries in systole, with this technique, an FSD prepulse is used, allowing generation of dark blood images.53 The FSD prepulse consists of a 90°x–180°y–90°-x sequence interleaved with bipolar gradients. After excitation by the initial 90°x pulse, spins get dephased to a varying degree by the bipolar gradients depending on their velocities. The amount of this dephasing determines how constructively the last 90°-x pulse works on the spins, which results in different effective flip angles ranging from 0° to 180° for spins with different velocities. The resultant longitudinal magnetization is a cosine function over spin’s velocity, where the frequency of the sinusoidal fluctuation is proportional to the size of the bipolar gradient. Then, with sufficiently large bipolar gradients, spin velocity variations within each voxel cause large intravoxel dephasing and make the net signal nearly zero. To obtain dark artery images, the FSD prepulse is played during systole using cardiac triggering, followed by the 3D bSSFP readout. To obtain bright artery images, the prepulse is played with all the bipolar gradients turned off, which becomes the same as typical T2 preparation prepulse (Figure IV and V in the Data Supplement).

    The strength and duration of the bipolar gradient determine the degree of the flow sensitivity; this parameter must be carefully chosen by the user. The use of large bipolar gradients (and therefore too large flow sensitivity) may result in signal from unwanted contamination from venous blood and even stationary tissues due to the diffusion effect, whereas the use of small bipolar gradients may fail to delineate small vessels with low-flow velocity. The pros and cons of the FSD-based NC-MRA are similar to those of the spin-echo-based subtractive technique (Table 2). The use of 3D encoding allows for high spatial resolution in all 3 dimensions, but the need for 2 acquisitions increases the scan time and the risk of motion-related artifacts. A practical drawback of FSD NC-MRA is that it is not commercially available at this time.

    Clinical Utility and Preferred Vascular Application(s)

    FSD-prepared 3D bSSFP provides good SNR and image resolution due to the T2-preparation before FSD module but requires high B0 homogeneity. Liu et al37 showed that, when compared with traditional CE-MRA in the evaluation of foot arteries, the technique has a high percentage of diagnostic arterial segments (92%), with high interobserver agreement and good values of SNR and CNR. The average sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of FSD MRA were 88%, 93%, 81%, 96%, and 92%. The technique has been used in the evaluation of the calf arteries at both 1.5T35,36,38 and 3T39,40 B0 field strength, demonstrating good sensitivity and negative predictive value compared with CE-MRA as reference standard and high sensitivity and positive predictive value compared with DSA (Table 1). The relatively low specificity in the evaluation of the calf arteries may be explained by flow-related artifacts due to the long acquisition times affecting patient compliance, the inhomogeneity of magnetic field at 3T, and the imprecise choice of acquisition parameters, in particular the amplitude and the direction of the bipolar gradients. Zhang et al28 compared QISS and FSD MRA, using CE-MRA as standard reference. They found no significant difference in the number of diagnostic arterial segments and higher SNR and CNR values of FSD MRA than QISS. Authors showed no difference in sensitivity (95% versus 93%; P>0.05) and negative predictive value (98% versus 97%; P>0.05) between FSD and QISS for detecting stenosis >50%. FSD showed higher specificities (99% versus 92%) and diagnostic accuracy (98% versus 92%) compared with QISS. The main limitation of FSD MRA when compared with QISS is the longer scanning time, which makes this technique less useful in noncompliant patients.

    Shaida38 et al reported a sensitivity of 65% and a specificity of 93% for the calf district evaluation in a cohort of 24 patients. This result could be explained by the high rate of multifocal disease in PAD patients, which make the image interpretation more challenging.

    Although this technique is still not commercially available, its strengths reside in the possibility to modulate the characteristics of the bipolar gradient to determine the degree of the flow sensitivity and in the sub-millimetric spatial resolution. These features make the technique suitable for evaluation of distal arterial segments (calf or foot) in patients with known history or suspected PAD (Table 3).

    Velocity-Sensitive Flow-Dependent Approaches

    Phase Contrast MRA

    This MRA approach was originally developed starting from the idea that spins in moving protons in blood incur a net phase difference that is greater than stationary protons.54,55 The application of a bipolar gradient to an imaging volume containing vessels will then result in stationary protons experiencing no net phase shift, in contrast to the moving protons that experience a net phase shift proportional to their velocity and direction. Bipolar gradients can be applied along one anatomic axis or along 2 or more axes simultaneously to measure flowing spin phase shift in an arbitrary direction stenosis. The net phase shift experienced by the moving protons is proportional to the velocity of blood, with the maximal phase shift occurring at a ±180° phase shift. The amplitude, duration, and spacing of the bipolar gradients are controlled by an operator-dependent parameter known as velocity encoding. When a certain velocity encoding is selected, the MR system modifies the strength of the flow encoding (bipolar) gradients so that protons moving at the desired velocity will have a full 180° phase shift. The main disadvantage of phase contrast (PC)-MRA are the long scan time and the high sensitivity to signal losses caused by turbulence and vessel tortuosity. Given that the technique does not have imaging quality information, its utility is primarily in assessment of stenosis. A different approach to PC technique is the combination of 3D spatial encoding, 3-directional velocity encoding and cine acquisition, proposed by Wigström in 1996.56 This 4D PC approach allows time-resolved flow and depiction of temporal evolution of flow patterns in an anatomic region.57 Due to long scan times and relatively low spatial resolution, the applications of the technique in the study of the lower limbs’ arteries are currently limited (Table 2). Four-dimensional technique can be used for in vivo evaluation of atherosclerotic plaques in large vessels.58

    Table 1. Clinical Applications of NC-MRA Sequences

    Arterial DistrictNumber of PatientsComparisonTechnical NotesSensitivitySpecificity
    QISS
     Hodnett et al16Lower extremities53CE-MRA, 15 patients had DSA1.5T scannerCE-MRA as reference: 88.35%*CE-MRA as reference: 95.55%*
    DSA as reference: 91.0%DSA as reference: 96.6%
     Hodnett et al17Lower extremities25CE-MRA, 9 patients had DSA1.5T scannerCE-MRA as reference: 89.75%*CE-MRA as reference: 96.4%*
    DSA as reference: 96.2%DSA as reference: 96.1%
     Klasen et al23Lower extremities27CE-MRA1.5T scanner98.6%96.0%
     Ward et al24Lower extremities20CE-MRA1.5T scanner84.9%95.6%
     Knobloch et al26Lower extremities25CE-MRA3T scanner84.5%*96.1%*
     Amin et al18Lower extremities25CE-MRA, 9 patients had DSA3T scannerCE-MRA as reference: 94.7%*CE-MRA as reference: 97.75%*
    DSA as reference: 91.7%DSA as reference: 97.7%
     Thierfelder et al25Lower extremities21CE-MRA3T scanner94.1%97.8%
     Hansmann et al19Lower extremities16CE-MRA, 8 patients had DSA3T scannerCE-MRA as reference: 81.1%*CE-MRA as reference: 83.45%*
    DSA as reference: 100%*DSA as reference: 76.5%*
     Zhang et al28Calf26CE-MRA1.5T scanner93%94%
     Wagner et al20Lower extremities32DSA3T scanner83.5%93.9%
     Wu et al21Lower extremities32DSAQISS on 3T scanner and CTA were performed with DSA as standard referenceQISS vs DSA 93.75%*QISS Vs DSA 97.23%*
    CTA vs DSA 89.62%*CTA vs DSA 96.53%*
     Knobloch et al27Calf42CE-MRA3T scanner79.5%*77%*
     Altaha et al22Lower extremities19DSA1.5T scanner86.5%*96%*
     Varga-Szemes et al29Lower extremities30DSA1.5T scanner CTA with Dual Source Energy scanner performed in all patients, DSA within 50 days was performed as standard referenceQISS vs DSA 84.9%QISS vs DSA 97.2%
    CTA vs DSA 87.3%CTA vs DSA 95.4%
    3D FSE
     Lim et al30Calf36CE-MRA1.5T scanner85.4%75.8%
     Gutzeit et al31Thigh43DSA1.5T scannerThigh 95.6%*Thigh 97.4%*
     CalfCalf 95.2%*Calf 87.5%*
     Haneder et al32Calf36CE-MRA3T scanner98.2%72.7%
     Nakamura et al33Lower limb13CTA1.5T scanner97%96%
     Ward et al24Lower extremities20CE-MRA1.5T scanner87.3%87.0%
     Schubert et al34Pedal arteries20DSA3T scanner96%80%
     Altaha et al22Lower extremities19DSA1.5T scanner. 90% to 96% of segments obtained with 3D-FSE MRA were rated as nondiagnostic or poor. No further sensitivity/specificity calculation was possible
    FSD preparation
     Priest et al35Calf34CE-MRA1.5 scanner81.7%90.9%
     Liu et al36Foot32 healthy volunteers and 38 patientsCE-MRA1.5 scanner88%93%
     Liu et al37Calf45CE-MRA1.5 scanner97%96%
     Zhang et al28Calf26CE-MRA1.5 scanner95%98%
     Shaida et al38Calf24CE-MRA1.5 scanner65.3%92.7%
     Zhang et al39Calf20CE-MRA, 6 patients had DSA3T ScannerCE-MRA as reference 96.40%CE-MRA as reference 93.00%
    DSA as reference 100%DSA as reference 94.1%
     Liu et al40Calf16CE-MRA, DSA3T ScannerCE-MRA as reference 84.7%*CE-MRA as reference 94.7%*
    DSA as reference 86.2%DSA as reference 86.3%
    Velocity-selective MRA
     Shin et al41Lower extremities31DSA (24 patients)1.5T scanner79.4%95.1%

    Diagnostic metrics provided on a vessel segment basis. 3D FSE indicates 3 dimensional fast spin-echo; CE-MRA, contrast-enhanced magnetic resonance angiography; CTA, computed tomography angiography; DSA, digital subtraction angiography; FSD, flow-sensitive dephasing; MRA, magnetic resonance angiography; NC-MRA, noncontrast magnetic resonance angiography; and QISS, quiescent interval slice-selective.

    *Value is the mean of the 2 individual reader scores reported.

    †Value is the mean of the 3 individual reader scores reported.

    Table 2. Technical Details Summary of NC-MRA Sequences

    TechniqueDescriptionAdvantagesDisadvantagesTechnical Aspects
    Inflow dependent
     TOFInflow-based technique that provides contrast from fresh unsaturated blood.Loss of signal induced by flow-induced spin dephasing and saturation effects in tortuous vessels with in-plane flow.Long scan time. Can only assess one single station at a time.EKG gated with images acquired perpendicular to imaging plane.
     QISSInflow-based technique that addresses limitations of TOF by reducing scan times, arterial saturation, single-shot slices that uses balanced SSFP readout.Clinically acceptable scan times (7–8 min for pelvis to ankles) allowing coverage of pelvis, thighs, and lower extremity vessels.
    Helpful in low-flow situations such as those with stenosis. Most suited for assessment of PAD patients.
    Suppression of in-plane-oriented vessel segments that reside within the saturation region.
    Limited inferior-superior resolution.
    Sensitivity to off-resonance artifacts from metallic implants, and air-filled bowel loops
    EKG gated acquired.
    Cardiac phase and flow dependent techniques
     3D-FSECardiac phase dependent technique that relies on subtraction of systolic and diastolic images to provide pure arterial or venous phase images.High spatial resolution; relatively insensitive to B0 field variation allowing their use with large FOV and high field strength.Longer scan times to cover multiple stations; poor visualization of pelvic vessels and small-caliber arteries, particularly of calf and foot district especially in CLI patients.EKG gated. Needs a systolic and diastolic acquisition.
     FSD preparationCardiac phase dependent technique that relies on subtraction of systolic and diastolic images to provide pure arterial or venous phase images but relies on a magnetization preparation pulse to suppress flow in systole.FSD prepulse allows complete flow signal suppression in systolic images.Flow-related artifacts and venous contamination are issues limiting applicability in PAD and especially in more severe PAD patients such as CLI.EKG gated. Needs a systolic and diastolic acquisition.
     PC-MRABi-polar gradients applied to measure flowing spins phase shift.Allows quantification of flow velocity.Long scan times. High sensitivity to signal losses caused by turbulence and vessel tortuosity.Not suitable for morphological evaluation of lower limbs arteries.
    Primarily used for stenosis assessment.
     VS-MRAVS magnetization preparation pulse modulates flowing spins as function of their velocity and suppresses signal from stationary tissues and slow venous blood.Reduced scan times because images are acquired only during systole. Less sensitive to cardiac arrhythmia.Sensitive to B0 and B1 inhomogeneity.EKG gated: no diastolic acquisition required.

    3D-FSE indicates 3-dimensional fast spin echo; CLI, critical limb ischemia; EKG, electrocardiogram; FOV, field of view; FSD, flow-sensitive dephasing; NC-MRA, noncontrast magnetic resonance angiography; PAD, peripheral arterial disease; PC-MRA, phase contrast magnetic resonance angiography; QISS, quiescent interval slice-selective; SSFP, steady-state free precession; TOF, time of flight; and VS-MRA, velocity-sensitive magnetic resonance angiography.

    Table 3. Summary of Clinical Application of NC-MRA Techniques

    TechniqueDisadvantagesClinical Applications
    Inflow dependent
     TOFLong scan times. Separate acquisition for each district.Limited for lower limb arteries. Currently most used for intracranial and extracranial vessels evaluation.
     QISSSuppression of in-plane-oriented vessel segments that reside within the saturation region.
    Limited inferior-superior resolution.
    Sensitivity to off-resonance artifacts from metallic implants and air-filled bowel loops.
    Evaluation of lower limb arteries in patients without metallic implants in femoral and calf vessels.
    Cardiac phase and flow dependent techniques
     3D-FSELow image quality in the visualization of small vessels with high-grade stenoses.Evaluation of the distal abdominal aorta and iliac arteries in patients with and without metallic stent or prosthesis.
     FSD preparationNot commercially available. Long scan times.Evaluation of distal arterial segments (calf or foot) in patients with known history or suspected PAD.
     PC-MRALong scan times.Currently not suitable for morphological evaluation of lower limb arteries.
    Useful for degree of stenosis assessment.
     VS-MRAHigh sensitivity to the effects of B0 and B1 inhomogeneity.Evaluation of lower limb arteries in arterial districts not affected by sources of magnetic field inhomogeneity (air, metallic stets, and prosthesis) such as femoral or calf arteries in patients with history of cardiac disease.

    3D-FSE indicates 3-dimensional fast spin echo; FSD, flow-sensitive dephasing; NC-MRA, noncontrast magnetic resonance angiography; PAD, peripheral arterial disease; QISS, quiescent interval slice-selective; TOF, time of flight; and VS-MRA, velocity-sensitive magnetic resonance angiography.

    Velocity-Selective MRA

    Velocity-selective MRA (VS-MRA) has been recently introduced as another promising noncontrast-enhanced angiography method.59,60 The key component of this method is a velocity-selective magnetization preparation pulse which modulates each magnetic spin as an explicit and flexible function of its velocity, but without regards to its spatial location.61 This prepulse may sound similar to the FSD prepulse in that both excite spins in a flow-sensitive fashion. The important difference, however, is that the VS prepulse works by suppressing the background tissues and slow venous blood while preserving arterial blood signal and, thus, generating positive arterial contrast directly in a single acquisition. However, the FSD prepulse can only suppress flowing spins, thereby requiring acquisition of reference (bright artery) image and subtraction of 2 images. The initial version of VS preparation pulse consists of multiple hard RF pulses of small flip angle, interleaved with repeated bipolar gradients. The pulse sequence for VS-MRA is cardiac gated and plays the VS prepulse near the time of peak systolic flow by adjusting a trigger delay typically based on a prior PC flow measurement. For a segmented 3D acquisition that follows the VS prepulse, balanced SSFP readouts are preferred to further enhance arterial signal, while gradient-echo readout can also be used to avoid potential banding artifacts at high fields.

    Due to the use of 3D encoding, VS-MRA can achieve high spatial resolution and large field of view in all three dimensions, similarly to the 3D subtractive methods based on FSE readout or FSD prepulse. In addition, VS-MRA requires only one acquisition, which makes it less time-consuming and with less potential for motion-induced artifacts compared with the other subtractive methods. Moreover, because the velocity sensitization of VS-MRA happens during systolic phases only, this technique is not sensitive to cardiac arrhythmia, which alters the diastole significantly but the systole minimally.62,63 Despite these compelling features, the effects of B0 and B1 inhomogeneity may manifest as arterial signal loss and stripe artifacts particularly at high field (Table 2). Relevant recent studies include application of optimized composite pulse to enhance the immunity to the field offsets and alternate application of phase-cycled VS prepulses to remove the stripe artifact.64,65

    Clinical Utility and Preferred Vascular Application(s)

    The first clinical testing of VS-MRA in a cohort of PAD patients was recently reported with DSA as the reference standard.41 The diagnostic sensitivity for detecting significant stenosis was 79.4% (averaged over 3 independent reviewers) when calculated on a per-segment basis and 92.1% when calculated on a per-region basis. The specificity was 95.1% on a per-segment basis and 94.0% on a per-region basis. The average of image quality score was 2.77 in the scale of 0 (nondiagnostic) to 3 (excellent). Figure 6 illustrates representative VS-MRA and DSA images in 3 PAD patients with moderate, advanced, and severe stenoses, respectively. While this initial test demonstrates the potential of VS-MRA, its clinical value needs to be further verified through comparisons with gadolinium-enhanced MRA and other nongadolinium-enhanced techniques.

    Figure 6.

    Figure 6. Velocity-selective magnetic resonance angiography (VS-MRA) and digital subtraction angiography (DSA) images in 3 peripheral arterial disease patients with Rutherford class I, III, and IV, respectively from the left to the right. The MR angiograms show excellent agreement with the DSA images in identifying narrowings of various degrees. In particular, VS-MRA well delineates diffuse small vessels in the third case because of high-velocity sensitivity and high 3D spatial resolution. Reprinted from Shin et al41 with permission. Copyright ©2018, Journal of Magnetic Resonance Imaging.

    Despite the need of further clinical verifications, the low sensitivity to cardiac arrhythmia and the high sensitivity to the effects of B0 and B1 inhomogeneity may render this sequence suitable for the evaluation of lower limb arteries in arterial districts not affected by sources of magnetic field inhomogeneity (air, metallic stets, and prosthesis) such as femoral or calf arteries in patients with knows history of cardiac disease (Table 3).

    Future Directions

    There are several new NC-MRA techniques that appear promising and may serve a role in the future.66,67

    Arterial spin labeling technique relies on the application of a tagging pulse applied to a slab of tissue upstream from the imaging volume that inverts the magnetization of water molecules. A control image is acquired on the selected region before the application of the tagging pulse, and a new image is acquired after the application of the tagging pulse in the selected region of interest to measure the signal difference of the tagged blood flow from the untagged image. With this approach, the evaluation of lower limbs perfusion is possible.68,69 Blood oxygenation level–dependent imaging relies on the evaluation of regional differences in blood flow features. When a region increases its perfusion, the extraction of oxygen from the local vascular bed determines an initial drop in oxygenated hemoglobin and an increase in local carbon dioxide and deoxygenated hemoglobin levels. The ability to detect the difference between the amount of these products resides in the different magnetic properties of oxygenated and deoxygenated hemoglobin. Deoxygenated hemoglobin is paramagnetic, whereas oxygenated hemoglobin is not, so the former will cause local dephasing of protons, reducing signal intensity from imaged tissues. Lower limb perfusion in patients with PAD has been studied with this approach,70–72 which has been extensively used for brain functional imaging.73 Atherosclerotic plaque imaging is an important challenge for magnetic resonance imaging technology because plaque composition influences the subsequent risk for vascular occlusion.67 Several approaches have been implemented and are under investigation for atherosclerotic plaques imaging: (1) susceptibility imaging aiming to study plaque composition taking advantage of the different magnetic properties of plaque components (eg, calcification and intraplaque hemorrhage lead to increased magnetic susceptibility). Highly susceptive components have short T2*, which can be measured using multi-echo imaging techniques. (2) Plaque components, such as lipoproteins and collagen, may have short T2 values to be directly imaged with standard FSE techniques. Ultra-short echo time and magnetization transfer imaging techniques have been introduced to obtain signal from tissues with this characteristic. (3) Microscopic structure of the plaque components can influence the magnetic resonance imaging signal on diffusion-weighted imaging. Regions with smaller diffusion coefficients undergo less dephasing and appear brighter on the resulting diffusion-weighted imaging image (eg, necrotic core regions show lower diffusion coefficients than fibrous tissue). In the future, multiple approaches could provide stenoses severity and phenotypic characterization of lower extremity plaque and could leverage machine learning and artificial intelligence approaches that may be warranted given the need for accurate and reproducible data extraction and comparisons.

    Conclusions

    The application of NC-MRA techniques has seen a recent resurgence of interest in patients with PAD. In contrast to older techniques, such as TOF and PC-MRA, newer approaches such as QISS, 3D-FSE, and VS-MRA provide superior ability especially in patients with PAD and are theoretically an attractive alternative to CTA or DSA and may provide a practical platform to assess PAD patients.

    Footnotes

    The Data Supplement is available at https://www.ahajournals.org/doi/suppl/10.1161/CIRCIMAGING.118.008844.

    Sanjay Rajagopalan, MD, Harrington Heart and Vascular Institute, University Hospitals, Case Cardiovascular Research Institute, Case Western Reserve School of Medicine, Wolstein Research Bldg, Rm 4405, Cleveland, OH 44106-010. Email

    References

    • 1. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2017; 135:e726–e779. doi: 10.1161/CIR.0000000000000471LinkGoogle Scholar
    • 2. Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I; ESC Scientific Document Group. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).Eur Heart J. 2018; 39:763–816. doi: 10.1093/eurheartj/ehx095CrossrefMedlineGoogle Scholar
    • 3. O’Hare AM, Glidden DV, Fox CS, Hsu CY. High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000.Circulation. 2004; 109:320–323. doi: 10.1161/01.CIR.0000114519.75433.DDLinkGoogle Scholar
    • 4. Grobner T. Gadolinium–a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?Nephrol Dial Transplant. 2006; 21:1104–1108. doi: 10.1093/ndt/gfk062CrossrefMedlineGoogle Scholar
    • 5. Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.Radiology. 2014; 270:834–841. doi: 10.1148/radiol.13131669CrossrefMedlineGoogle Scholar
    • 6. Stojanov DA, Aracki-Trenkic A, Vojinovic S, Benedeto-Stojanov D, Ljubisavljevic S. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.Eur Radiol. 2016; 26:807–815. doi: 10.1007/s00330-015-3879-9MedlineGoogle Scholar
    • 7. Murata N, Gonzalez-Cuyar LF, Murata K, Fligner C, Dills R, Hippe D, Maravilla KR. Macrocyclic and Other Non-Group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function.Invest Radiol. 2016; 51:447–453. doi: 10.1097/RLI.0000000000000252CrossrefMedlineGoogle Scholar
    • 8. Rasschaert M, Idée JM, Robert P, Fretellier N, Vives V, Violas X, Ballet S, Corot C. Moderate renal failure accentuates T1 signal enhancement in the deep cerebellar nuclei of gadodiamide-treated rats.Invest Radiol. 2017; 52:255–264. doi: 10.1097/RLI.0000000000000339CrossrefMedlineGoogle Scholar
    • 9. Wheaton AJ, Miyazaki M. Non-contrast enhanced MR angiography: physical principles.J Magn Reson Imaging. 2012; 36:286–304. doi: 10.1002/jmri.23641CrossrefMedlineGoogle Scholar
    • 10. Edelman RR, Carr M, Koktzoglou I. Advances in non-contrast quiescent-interval slice-selective (QISS) magnetic resonance angiography.Clin Radiol. 2019; 74:29–36. doi: 10.1016/j.crad.2017.12.003CrossrefMedlineGoogle Scholar
    • 11. Laub GA. Time-of-flight method of MR angiography.Magn Reson Imaging Clin N Am. 1995; 3:391–398.CrossrefMedlineGoogle Scholar
    • 12. Offerman EJ, Hodnett PA, Edelman RR, Koktzoglou I. Nonenhanced methods for lower-extremity MRA: a phantom study examining the effects of stenosis and pathologic flow waveforms at 1.5T.J Magn Reson Imaging. 2011; 33:401–408. doi: 10.1002/jmri.22457CrossrefMedlineGoogle Scholar
    • 13. Heiserman JE, Drayer BP, Fram EK, Keller PJ, Bird CR, Hodak JA, Flom RA. Carotid artery stenosis: clinical efficacy of two-dimensional time-of-flight MR angiography.Radiology. 1992; 182:761–768. doi: 10.1148/radiology.182.3.1535891CrossrefMedlineGoogle Scholar
    • 14. Hutter J, Grimm R, Forman C, Hornegger J, Schmitt P. Highly undersampled peripheral Time-of-Flight magnetic resonance angiography: optimized data acquisition and iterative image reconstruction.MAGMA. 2015; 28:437–446. doi: 10.1007/s10334-014-0477-9CrossrefMedlineGoogle Scholar
    • 15. Edelman RR, Sheehan JJ, Dunkle E, Schindler N, Carr J, Koktzoglou I. Quiescent-interval single-shot unenhanced magnetic resonance angiography of peripheral vascular disease: technical considerations and clinical feasibility.Magn Reson Med. 2010; 63:951–958. doi: 10.1002/mrm.22287CrossrefMedlineGoogle Scholar
    • 16. Hodnett PA, Koktzoglou I, Davarpanah AH, Scanlon TG, Collins JD, Sheehan JJ, Dunkle EE, Gupta N, Carr JC, Edelman RR. Evaluation of peripheral arterial disease with nonenhanced quiescent-interval single-shot MR angiography.Radiology. 2011; 260:282–293. doi: 10.1148/radiol.11101336CrossrefMedlineGoogle Scholar
    • 17. Hodnett PA, Ward EV, Davarpanah AH, Scanlon TG, Collins JD, Glielmi CB, Bi X, Koktzoglou I, Gupta N, Carr JC, Edelman RR. Peripheral arterial disease in a symptomatic diabetic population: prospective comparison of rapid unenhanced MR angiography (MRA) with contrast-enhanced MRA.AJR Am J Roentgenol. 2011; 197:1466–1473. doi: 10.2214/AJR.10.6091CrossrefMedlineGoogle Scholar
    • 18. Amin P, Collins JD, Koktzoglou I, Molvar C, Markl M, Edelman RR, Carr JC. Evaluating peripheral arterial disease with unenhanced quiescent-interval single-shot MR angiography at 3 T.AJR Am J Roentgenol. 2014; 202:886–893. doi: 10.2214/AJR.13.11243CrossrefMedlineGoogle Scholar
    • 19. Hansmann J, Morelli JN, Michaely HJ, Riester T, Budjan J, Schoenberg SO, Attenberger UI. Nonenhanced ECG-gated quiescent-interval single shot MRA: image quality and stenosis assessment at 3 tesla compared with contrast-enhanced MRA and digital subtraction angiography.J Magn Reson Imaging. 2014; 39:1486–1493. doi: 10.1002/jmri.24324CrossrefMedlineGoogle Scholar
    • 20. Wagner M, Knobloch G, Gielen M, Lauff MT, Romano V, Hamm B, Kröncke T. Nonenhanced peripheral MR-angiography (MRA) at 3 Tesla: evaluation of quiescent-interval single-shot MRA in patients undergoing digital subtraction angiography.Int J Cardiovasc Imaging. 2015; 31:841–850. doi: 10.1007/s10554-015-0612-3CrossrefMedlineGoogle Scholar
    • 21. Wu G, Yang J, Zhang T, Morelli JN, Giri S, Li X, Tang W. The diagnostic value of non-contrast enhanced quiescent interval single shot (QISS) magnetic resonance angiography at 3T for lower extremity peripheral arterial disease, in comparison to CT angiography.J Cardiovasc Magn Reson. 2016; 18:71. doi: 10.1186/s12968-016-0294-6CrossrefMedlineGoogle Scholar
    • 22. Altaha MA, Jaskolka JD, Tan K, Rick M, Schmitt P, Menezes RJ, Wintersperger BJ. Non-contrast-enhanced MR angiography in critical limb ischemia: performance of quiescent-interval single-shot (QISS) and TSE-based subtraction techniques.Eur Radiol. 2017; 27:1218–1226. doi: 10.1007/s00330-016-4448-6CrossrefMedlineGoogle Scholar
    • 23. Klasen J, Blondin D, Schmitt P, Bi X, Sansone R, Wittsack HJ, Kröpil P, Quentin M, Kuhlemann J, Miese F, Heiss C, Kelm M, Antoch G, Lanzman RS. Nonenhanced ECG-gated quiescent-interval single-shot MRA (QISS-MRA) of the lower extremities: comparison with contrast-enhanced MRA.Clin Radiol. 2012; 67:441–446. doi: 10.1016/j.crad.2011.10.014CrossrefMedlineGoogle Scholar
    • 24. Ward EV, Galizia MS, Usman A, Popescu AR, Dunkle E, Edelman RR. Comparison of quiescent inflow single-shot and native space for nonenhanced peripheral MR angiography.J Magn Reson Imaging. 2013; 38:1531–1538. doi: 10.1002/jmri.24124CrossrefMedlineGoogle Scholar
    • 25. Thierfelder KM, Meimarakis G, Nikolaou K, Sommer WH, Schmitt P, Kazmierczak PM, Reiser MF, Theisen D. Non-contrast-enhanced MR angiography at 3 Tesla in patients with advanced peripheral arterial occlusive disease.PLoS One. 2014; 9:e91078. doi: 10.1371/journal.pone.0091078CrossrefMedlineGoogle Scholar
    • 26. Knobloch G, Gielen M, Lauff MT, Romano VC, Schmitt P, Rick M, Kröncke TJ, Huppertz A, Hamm B, Wagner M. ECG-gated quiescent-interval single-shot MR angiography of the lower extremities: initial experience at 3 T.Clin Radiol. 2014; 69:485–491. doi: 10.1016/j.crad.2013.12.006CrossrefMedlineGoogle Scholar
    • 27. Knobloch G, Lauff MT, Hirsch S, Schwenke C, Hamm B, Wagner M. Nonenhanced magnetic resonance angiography (MRA) of the calf arteries at 3 Tesla: intraindividual comparison of 3D flow-dependent subtractive MRA and 2D flow-independent non-subtractive MRA.Eur Radiol. 2016; 26:4585–4594. doi: 10.1007/s00330-016-4246-1CrossrefMedlineGoogle Scholar
    • 28. Zhang N, Zou L, Huang Y, Liu D, Tang Y, Fan Z, Chen H, Liu X. Non-Contrast Enhanced MR Angiography (NCE-MRA) of the Calf: a direct comparison between Flow-Sensitive Dephasing (FSD) prepared Steady-State Free Precession (SSFP) and Quiescent-Interval Single-Shot (QISS) in patients with diabetes.Yang X, ed. PloS One. 2015; 10:e0128786. doi: 10.1371/journal.pone.0128786MedlineGoogle Scholar
    • 29. Varga-Szemes A, Wichmann JL, Schoepf UJ, Suranyi P, De Cecco CN, Muscogiuri G, Caruso D, Yamada RT, Litwin SE, Tesche C, Duguay TM, Giri S, Vliegenthart R, Todoran TM. Accuracy of Noncontrast quiescent-interval single-shot lower extremity mr angiography versus CT angiography for diagnosis of peripheral artery disease: comparison with digital subtraction angiography.JACC Cardiovasc Imaging. 2017; 10(10pt A):1116–1124. doi: 10.1016/j.jcmg.2016.09.030CrossrefMedlineGoogle Scholar
    • 30. Lim RP, Hecht EM, Xu J, Babb JS, Oesingmann N, Wong S, Muhs BE, Gagne P, Lee VS. 3D nongadolinium-enhanced ECG-gated MRA of the distal lower extremities: preliminary clinical experience.J Magn Reson Imaging. 2008; 28:181–189. doi: 10.1002/jmri.21416CrossrefMedlineGoogle Scholar
    • 31. Gutzeit A, Sutter R, Froehlich JM, Roos JE, Sautter T, Schoch E, Giger B, Wyss M, Graf N, von Weymarn C, Jenelten R, Binkert CA, Hergan K. ECG-triggered non-contrast-enhanced MR angiography (TRANCE) versus digital subtraction angiography (DSA) in patients with peripheral arterial occlusive disease of the lower extremities.Eur Radiol. 2011; 21:1979–1987. doi: 10.1007/s00330-011-2132-4CrossrefMedlineGoogle Scholar
    • 32. Haneder S, Attenberger UI, Riffel P, Henzler T, Schoenberg SO, Michaely HJ. Magnetic resonance angiography (MRA) of the calf station at 3.0 T: intraindividual comparison of non-enhanced ECG-gated flow-dependent MRA, continuous table movement MRA and time-resolved MRA.Eur Radiol. 2011; 21:1452–1461. doi: 10.1007/s00330-011-2063-0CrossrefMedlineGoogle Scholar
    • 33. Nakamura K, Miyazaki M, Kuroki K, Yamamoto A, Hiramine A, Admiraal-Behloul F. Noncontrast-enhanced peripheral MRA: technical optimization of flow-spoiled fresh blood imaging for screening peripheral arterial diseases.Magn Reson Med. 2011; 65:595–602. doi: 10.1002/mrm.22614CrossrefMedlineGoogle Scholar
    • 34. Schubert T, Takes M, Aschwanden M, Klarhoefer M, Haas T, Jacob AL, Liu D, Gutzeit A, Kos S. Non-enhanced, ECG-gated MR angiography of the pedal vasculature: comparison with contrast-enhanced MR angiography and digital subtraction angiography in peripheral arterial occlusive disease.Eur Radiol. 2016; 26:2705–2713. doi: 10.1007/s00330-015-4068-6CrossrefMedlineGoogle Scholar
    • 35. Priest AN, Joubert I, Winterbottom AP, See TC, Graves MJ, Lomas DJ. Initial clinical evaluation of a non-contrast-enhanced MR angiography method in the distal lower extremities.Magn Reson Med. 2013; 70:1644–1652. doi: 10.1002/mrm.24626CrossrefMedlineGoogle Scholar
    • 36. Liu X, Zhang N, Fan Z, Feng F, Yang Q, Zheng H, Liu P, Li D. Detection of infragenual arterial disease using non-contrast-enhanced MR angiography in patients with diabetes.J Magn Reson Imaging. 2014; 40:1422–1429. doi: 10.1002/jmri.24477CrossrefMedlineGoogle Scholar
    • 37. Liu X, Fan Z, Zhang N, Yang Q, Feng F, Liu P, Zheng H, Li D. Unenhanced MR angiography of the foot: initial experience of using flow-sensitive dephasing-prepared steady-state free precession in patients with diabetes.Radiology. 2014; 272:885–894. doi: 10.1148/radiol.14132284CrossrefMedlineGoogle Scholar
    • 38. Shaida N, Priest AN, See TC, Winterbottom AP, Graves MJ, Lomas DJ. Evaluation of velocity-sensitized and acceleration-sensitized NCE-MRA for below-knee peripheral arterial disease.J Magn Reson Imaging. 2017; 45:1846–1853. doi: 10.1002/jmri.25533CrossrefMedlineGoogle Scholar
    • 39. Zhang N, Fan Z, Luo N, Bi X, Zhao Y, An J, Liu J, Chen Z, Fan Z, Li D. Noncontrast MR angiography (MRA) of infragenual arteries using flow-sensitive dephasing (FSD)-prepared steady-state free precession (SSFP) at 3.0 Tesla: comparison with contrast-enhanced MRA.J Magn Reson Imaging. 2016; 43:364–372. doi: 10.1002/jmri.25003CrossrefMedlineGoogle Scholar
    • 40. Liu J, Zhang N, Fan Z, Luo N, Zhao Y, Bi X, An J, Chen Z, Liu D, Wen Z, Fan Z, Li D. Image quality and stenosis assessment of non-contrast-enhanced 3-T magnetic resonance angiography in patients with peripheral artery disease compared with contrast-enhanced magnetic resonance angiography and digital subtraction angiography.PLoS One. 2016; 11:e0166467. doi: 10.1371/journal.pone.0166467MedlineGoogle Scholar
    • 41. Shin T, Menon RG, Thomas RB, Cavallo AU, Sarkar R, Crawford RS, Rajagopalan S. Unenhanced Velocity-Selective MR Angiography (VS-MRA): initial clinical evaluation in patients with peripheral artery disease.J Magn Reson Imaging. 2019; 49:744–751. doi: 10.1002/jmri.26268CrossrefMedlineGoogle Scholar
    • 42. Koktzoglou I, Murphy IG, Giri S, Edelman RR. Quiescent interval low angle shot magnetic resonance angiography of the extracranial carotid arteries.Magn Reson Med. 2016; 75:2072–2077. doi: 10.1002/mrm.25791CrossrefMedlineGoogle Scholar
    • 43. Edelman RR, Giri S, Pursnani A, Botelho MP, Li W, Koktzoglou I. Breath-hold imaging of the coronary arteries using Quiescent-Interval Slice-Selective (QISS) magnetic resonance angiography: pilot study at 1.5 Tesla and 3 Tesla.J Cardiovasc Magn Reson. 2015; 17:101. doi: 10.1186/s12968-015-0205-2CrossrefMedlineGoogle Scholar
    • 44. Koktzoglou I, Edelman RR. Super-resolution intracranial quiescent interval slice-selective magnetic resonance angiography.Magn Reson Med. 2018; 79:683–691. doi: 10.1002/mrm.26715CrossrefMedlineGoogle Scholar
    • 45. Edelman RR, Silvers RI, Thakrar KH, Metzl MD, Nazari J, Giri S, Koktzoglou I. Nonenhanced MR angiography of the pulmonary arteries using single-shot radial quiescent-interval slice-selective (QISS): a technical feasibility study.J Cardiovasc Magn Reson. 2017; 19:48. doi: 10.1186/s12968-017-0365-3CrossrefMedlineGoogle Scholar
    • 46. Mihai G, Chung YC, Kariisa M, Raman SV, Simonetti OP, Rajagopalan S. Initial feasibility of a multi-station high resolution three-dimensional dark blood angiography protocol for the assessment of peripheral arterial disease.J Magn Reson Imaging. 2009; 30:785–793. doi: 10.1002/jmri.21923CrossrefMedlineGoogle Scholar
    • 47. Mugler JP. Optimized three-dimensional fast-spin-echo MRI.J Magn Reson Imaging. 2014; 39:745–767. doi: 10.1002/jmri.24542CrossrefMedlineGoogle Scholar
    • 48. Meuli RA, Wedeen VJ, Geller SC, Edelman RR, Frank LR, Brady TJ, Rosen BR. MR gated subtraction angiography: evaluation of lower extremities.Radiology. 1986; 159:411–418. doi: 10.1148/radiology.159.2.3961174CrossrefMedlineGoogle Scholar
    • 49. Miyazaki M, Sugiura S, Tateishi F, Wada H, Kassai Y, Abe H. Non-contrast-enhanced MR angiography using 3D ECG-synchronized half-Fourier fast spin echo.J Magn Reson Imaging. 2000; 12:776–783.CrossrefMedlineGoogle Scholar
    • 50. Miyazaki M, Takai H, Sugiura S, Wada H, Kuwahara R, Urata J. Peripheral MR angiography: separation of arteries from veins with flow-spoiled gradient pulses in electrocardiography-triggered three-dimensional half-Fourier fast spin-echo imaging.Radiology. 2003; 227:890–896. doi: 10.1148/radiol.2273020227CrossrefMedlineGoogle Scholar
    • 51. Storey P, Atanasova IP, Lim RP, Xu J, Kim D, Chen Q, Lee VS. Tailoring the flow sensitivity of fast spin-echo sequences for noncontrast peripheral MR angiography.Magn Reson Med. 2010; 64:1098–1108. doi: 10.1002/mrm.22510CrossrefMedlineGoogle Scholar
    • 52. Mihai G, Chung YC, Merchant A, Simonetti OP, Rajagopalan S. T1-weighted-SPACE dark blood whole body magnetic resonance angiography (DB-WBMRA): initial experience.J Magn Reson Imaging. 2010; 31:502–509. doi: 10.1002/jmri.22049CrossrefMedlineGoogle Scholar
    • 53. Suttmeyer B, Teichgräber U, Rathke H, Albrecht L, Güttler F, Schnackenburg B, Hamm B, de Bucourt M. Initial experience with imaging of the lower extremity arteries in an open 1.0 Tesla MRI system using the triggered angiography non-contrast-enhanced sequence (TRANCE) compared to digital subtraction angiography (DSA).Biomed Tech (Berl). 2016; 61:383–392. doi: 10.1515/bmt-2014-0181CrossrefMedlineGoogle Scholar
    • 54. Bryant DJ, Payne JA, Firmin DN, Longmore DB. Measurement of flow with NMR imaging using a gradient pulse and phase difference technique.J Comput Assist Tomogr. 1984; 8:588–593.CrossrefMedlineGoogle Scholar
    • 55. Moran PR, Moran RA, Karstaedt N. Verification and evaluation of internal flow and motion. True magnetic resonance imaging by the phase gradient modulation method.Radiology. 1985; 154:433–441. doi: 10.1148/radiology.154.2.3966130CrossrefMedlineGoogle Scholar
    • 56. Wigström L, Sjöqvist L, Wranne B. Temporally resolved 3D phase-contrast imaging.Magn Reson Med. 1996; 36:800–803.CrossrefMedlineGoogle Scholar
    • 57. Markl M, Kilner PJ, Ebbers T. Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance.J Cardiovasc Magn Reson. 2011; 13:7. doi: 10.1186/1532-429X-13-7CrossrefMedlineGoogle Scholar
    • 58. Harloff A, Simon J, Brendecke S, Assefa D, Helbing T, Frydrychowicz A, Weber J, Olschewski M, Strecker C, Hennig J, Weiller C, Markl M. Complex plaques in the proximal descending aorta: an underestimated embolic source of stroke.Stroke. 2010; 41:1145–1150. doi: 10.1161/STROKEAHA.109.577775LinkGoogle Scholar
    • 59. Shin T, Worters PW, Hu BS, Nishimura DG. Non-contrast-enhanced renal and abdominal MR angiography using velocity-selective inversion preparation.Magn Reson Med. 2013; 69:1268–1275. doi: 10.1002/mrm.24356CrossrefMedlineGoogle Scholar
    • 60. Shin T, Hu BS, Nishimura DG. Off-resonance-robust velocity-selective magnetization preparation for non-contrast-enhanced peripheral MR angiography.Magn Reson Med. 2013; 70:1229–1240. doi: 10.1002/mrm.24561CrossrefMedlineGoogle Scholar
    • 61. de Rochefort L, Maître X, Bittoun J, Durand E. Velocity-selective RF pulses in MRI.Magn Reson Med. 2006; 55:171–176. doi: 10.1002/mrm.20751CrossrefMedlineGoogle Scholar
    • 62. Gharib AM, Herzka DA, Ustun AO, Desai MY, Locklin J, Pettigrew RI, Stuber M. Coronary MR angiography at 3T during diastole and systole.J Magn Reson Imaging. 2007; 26:921–926. doi: 10.1002/jmri.21056CrossrefMedlineGoogle Scholar
    • 63. Weissler AM, Harris WS, Schoenfeld CD. Systolic time intervals in heart failure in man.Circulation. 1968; 37:149–159.LinkGoogle Scholar
    • 64. Li W, Xu F, Schär M, Liu J, Shin T, Zhao Y, van Zijl PCM, Wasserman BA, Qiao Y, Qin Q. Whole-brain arteriography and venography: using improved velocity-selective saturation pulse trains.Magn Reson Med. 2018; 79:2014–2023. doi: 10.1002/mrm.26864CrossrefMedlineGoogle Scholar
    • 65. Shin T, Qin Q. Characterization and suppression of stripe artifact in velocity-selective magnetization-prepared unenhanced MR angiography.Magn Reson Med. 2018; 80:1997–2005. doi: 10.1002/mrm.27160CrossrefMedlineGoogle Scholar
    • 66. Mathew RC, Kramer CM. Recent advances in magnetic resonance imaging for peripheral artery disease.Vasc Med. 2018; 23:143–152. doi: 10.1177/1358863X18754694CrossrefMedlineGoogle Scholar
    • 67. Kerwin WS, Canton G. Advanced techniques for MRI of atherosclerotic plaque.Top Magn Reson Imaging. 2009; 20:217–225. doi: 10.1097/RMR.0b013e3181ea2853CrossrefMedlineGoogle Scholar
    • 68. Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water.Proc Natl Acad Sci U S A. 1992; 89:212–216.CrossrefMedlineGoogle Scholar
    • 69. Wu WC, Mohler E, Ratcliffe SJ, Wehrli FW, Detre JA, Floyd TF. Skeletal muscle microvascular flow in progressive peripheral artery disease: assessment with continuous arterial spin-labeling perfusion magnetic resonance imaging.J Am Coll Cardiol. 2009; 53:2372–2377. doi: 10.1016/j.jacc.2009.03.033CrossrefMedlineGoogle Scholar
    • 70. Langham MC, Floyd TF, Mohler ER, Magland JF, Wehrli FW. Evaluation of cuff-induced ischemia in the lower extremity by magnetic resonance oximetry.J Am Coll Cardiol. 2010; 55:598–606. doi: 10.1016/j.jacc.2009.08.068CrossrefMedlineGoogle Scholar
    • 71. Ledermann HP, Heidecker HG, Schulte AC, Thalhammer C, Aschwanden M, Jaeger KA, Scheffler K, Bilecen D. Calf muscles imaged at BOLD MR: correlation with TcPO2 and flowmetry measurements during ischemia and reactive hyperemia–initial experience.Radiology. 2006; 241:477–484. doi: 10.1148/radiol.2412050701CrossrefMedlineGoogle Scholar
    • 72. Englund EK, Langham MC, Li C, Rodgers ZB, Floyd TF, Mohler ER, Wehrli FW. Combined measurement of perfusion, venous oxygen saturation, and skeletal muscle T2* during reactive hyperemia in the leg.J Cardiovasc Magn Reson. 2013; 15:70. doi: 10.1186/1532-429X-15-70CrossrefMedlineGoogle Scholar
    • 73. Chen JE, Glover GH. Functional magnetic resonance imaging methods.Neuropsychol Rev. 2015; 25:289–313. doi: 10.1007/s11065-015-9294-9CrossrefMedlineGoogle Scholar